Date | Price Target | Rating | Analyst |
---|---|---|---|
6/26/2024 | $392.00 | Overweight | Piper Sandler |
6/24/2024 | $374.00 | Equal-Weight | Morgan Stanley |
4/2/2024 | $470.00 → $342.00 | Buy → Neutral | BofA Securities |
4/2/2024 | Buy → Neutral | BofA Securities | |
3/22/2024 | Mkt Perform | Raymond James | |
3/13/2024 | Buy → Hold | Argus | |
3/6/2024 | $356.00 | Equal Weight | Barclays |
1/26/2024 | $391.00 | Overweight → Neutral | Cantor Fitzgerald |
Builds On Ongoing Collaboration With Google Health To Develop Population Health Solutions And Address Healthcare Challenges
TD Cowen analyst Gary Taylor maintains Humana (NYSE:HUM) with a Buy and raises the price target from $396 to $407.
Cantor Fitzgerald analyst Sarah James reiterates Humana (NYSE:HUM) with a Neutral and maintains $360 price target.
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
SC 13G/A - HUMANA INC (0000049071) (Subject)
4 - HUMANA INC (0000049071) (Issuer)
In collaboration with a leading researcher and professor at Harvard University, Humana's first-of-its-kind study found better access to primary care and narrowed racial and socio-economic disparities for those receiving care from senior-focused primary care organizations. Humana Inc. (NYSE:HUM), one of the nation's leading health and well-being companies, recently published a study on senior-focused primary care — a value-based care model that tailors the environment and services of clinical organizations to the unique needs of older adults. Published in Health Affairs, this study is the first of its size and scope in analyzing this type of organization. This joint study, conducted in par
Humana Inc. (NYSE:HUM), a leading health and well-being company, announced a new value-based kidney care program with Evergreen Nephrology designed to advance quality of care and help optimize health outcomes for people living with chronic kidney disease and end-stage kidney disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240829112855/en/ Humana Medicare Advantage members who qualify for the program will now have access to a team of Evergreen professionals who work together in partnership with their nephrologist to provide individualized, whole-person care. Evergreen has nephrology practice partnerships in the following
CenterWell Home Health, one of America's largest home health providers, has launched its 20th annual Food Fundraising Drive, an effort to fight food insecurity in the communities it serves. Through Sept. 21, CenterWell Home Health branches across the country will be collecting food and funds to benefit local food banks in the 38 states it serves. CenterWell is also partnering with the national organization Feeding America to offer a single website to collect financial contributions from people wherever they are: CenterWell Home Health - Fundraising For Feeding America. Over the years, CenterWell Home Health has collected and donated more than 1.3 million meals to people in need. Accor
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
4 - HUMANA INC (0000049071) (Issuer)
Humana Inc. (NYSE:HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on October 25, 2024 to stockholders of record as of the close of business on September 30, 2024. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, mil
Reports 2Q24 earnings per share (EPS) of $5.62 on a GAAP basis, Adjusted EPS of $6.96; reports YTD 2024 EPS of $11.74 on a GAAP basis, $14.19 on an Adjusted basis Revises FY 2024 EPS guidance to 'approximately $12.81' (previously 'approximately $13.93') on a GAAP basis, while affirming Adjusted EPS of 'approximately $16.00'; affirms FY 2024 Insurance segment benefit ratio of approximately 90 percent Raises 2024 individual Medicare Advantage annual membership growth by 75,000 to now anticipate annual growth of approximately 225,000, or 4.2 percent Publishes Letter from the CEO and prepared management remarks to Investor Relations page of www.humana.com ahead of this morning's 9:00
Humana Inc. (NYSE:HUM) will release its financial results for the second quarter 2024 (2Q24), as well as prepared management remarks (in PDF format), on Wednesday, July 31, 2024, at 6:30 a.m. Eastern time. The company will host a live question and answer session at 9:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2024. To participate via telephone, please register in advance using this link, https://register.vevent.com/register/BI4837b56336d1453fb10a8fdaada5e1c0. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique regi
8-K - HUMANA INC (0000049071) (Filer)
10-Q - HUMANA INC (0000049071) (Filer)
8-K - HUMANA INC (0000049071) (Filer)
Piper Sandler initiated coverage of Humana with a rating of Overweight and set a new price target of $392.00
Morgan Stanley initiated coverage of Humana with a rating of Equal-Weight and set a new price target of $374.00
BofA Securities downgraded Humana from Buy to Neutral and set a new price target of $342.00 from $470.00 previously
David Dintenfass to lead new centralized function focused on customer experience, sales and marketing Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today that it has named David Dintenfass as President of Enterprise Growth. In this new role, Dintenfass will have responsibility for leading the company's growth plan with a primary focus on customer acquisition, retention, and experience. The creation of this position, and its emphasis on the customer and digital experience, will help Humana deliver on its long-term strategy and maximize long-term growth within the Medicare Advantage market. By 2030, one in five Americans is projected to be 65 years
Broussard, who reimagined senior-focused health care, announces he will step down after more than a decade of serving at the helm of the company Leading health insurer and health care services company Humana Inc. (NYSE:HUM) announced today it has named health care industry veteran Jim Rechtin as President and Chief Operating Officer of Humana Inc., effective January 8, 2024, as part of a long-planned CEO transition. He will report to Bruce Broussard, CEO, until the latter half of 2024 at which time Broussard will step down and Rechtin will assume the CEO role. Broussard joined Humana in 2011 and assumed the role of CEO in 2013. Over the last decade, he has led the company's transformati
The Humana Foundation, philanthropic arm of Humana Inc. (NYSE:HUM) for the past 41 years, today announced that David A. Jones Jr. has been elected to serve as Chairman of the Board of Directors, effective as of April 1, 2023. Jones is a current board member with over 26 years of dedicated service to the Humana Foundation. Since 1993, Jones has served on the Board of Directors for Humana Inc., a position from which he recently decided to retire as of April 20, 2023. "I am beyond honored with the opportunity to lead the Humana Foundation board and to further the 40-year history of the Foundation in Louisville, Kentucky and beyond as the foundation's reach has expanded nationally," said Mr.